Mirxes (HKG:2629) made an impressive trading debut in Hong Kong on Friday morning as its shares soared over 24% at the opening bell.
The Singapore-headquartered micro ribonucleic acid technology company opened at HK$29 per share, well above its IPO price of HK$23.30.